1 tracked superinvestor hold Solventum Corporation (SOLV), worth $538M combined, led by Nelson Peltz. Smart money is holding SOLV as of the latest 13F filings.
Current price
$75.96
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site…
Market cap
$11.6B
P/E
7.5
Div yield
0.0%
Revenue YoY
0.9%
Analyst target
$84
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$538M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding SOLV steady this quarter — buys and sells are balanced.
Solventum Corporation (SOLV) is held by 1 tracked funds worth $538M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The highest-conviction holder is Nelson Peltz, who has committed 14.9% of their portfolio to it.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 14.9% | $538M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own SOLV?
1 tracked funds hold Solventum Corporation (SOLV), the largest being Nelson Peltz (Trian Partners) at 14.9% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling SOLV?
In the most recent 13F quarter, 0 tracked funds added or opened SOLV and 0 trimmed it.
How much SOLV do tracked funds hold?
Combined disclosed long exposure to SOLV across tracked superinvestors is $538M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.